Dr Carl Webster was the host for 3rd UK & Ireland Early Career BBB Symposium. The BBB Symposium was held on the 22st of November 2013 at MedImmune, Cambridge, UK . The keynote presentation for this symposium was given by Dr Iain Chessell, Vice President Neuroscience, MedImmune. The conference flyer and programme are available for download.The symposium program is listed below;

 

3rd UK and Ireland Blood-Brain Barrier Symposium 2013

10.15-11.00: Registration and Refreshments

 

11.00-11.45: Keynote Session

The promise of crossing the blood brain barrier: challenges and progress. Iain Chessell, VP Neurosciences, MedImmune

 

11.45-12.45: Session 1

The secondary effect of Plasmodium falciparum infected red blood cells (PRBC) sequestration on blood-brain barrier (BBB) permeability in cerebral malaria (CM) an in-vitro study. Mohd Hamzah Mohd Nasir, Keele University

Contribution of the blood brain barrier (BBB) in neuro-immune communication following bacterial infection. Ursula Püntener, University of Southampton

CD4+ T cells and inflammatory cytokines potentiate Hepatitis C virus infection of the BBB. Nichola Fletcher, Birmingham University

 

12.45-13.45: Lunch and Poster Session

 

13:45-15:05: Session 2

Brain endothelial miR146a inhibits leucocyte adhesion through targeting NFAT5. Dongsheng Wu, Open University

Selective permeabilisation of the blood-brain barrier at sites of metastasis. John Connell, Oxford University

P-glycoprotein inhibition as a strategy to augment antidepressant delivery across the blood-brain barrier: preclinical pharmacokinetic and pharmacodynamic studies. Fionn O’Brien, University College Cork

Regional heterogeneity in the endothelial glycocalyx and basement membrane of the retinal vasculature. Marie O’Connor, Institute of Ophthalmology

 

15.05-15.30: Refreshments and posters

 

15:30-18.00: Session 3

Small gold nanoparticles: potential carriers of therapeutics across the blood-brain barrier. Radka Gromnicova Open University

Chemically functionalised carbon nanotubes as potential vectors for brain delivery in vivo. Julie Wang, Kings College, London

Modelling the Transport of Nanoparticles across the Blood‐Brain Barrier.  Gavin Fullstone, UCL

Making the transfer from Academic to Industry: Success in the recruitment process. Dinesh Chauhan, The Right Thing

Careers in industry, Lutz Jermutus, Senior Director, MedImmune

 

Poster Presentations

Abraham S, UCL. Inês Sá-Pereira1, University of Oxford. C. Wang, Open University. Sophie Nyborg, UCL. Zerin Alimajstorovic, Open University.

© 2015 by UK & Ireland Early Career Blood-Brain Barrier Symposium website created by David Dickens